But the prevalence rate of PALB2 mutations in a non-BRCA1/2 breast cancer population specifically selected for a family history of pancreatic cancer did not appear to be significantly increased compared to that observed in other breast cancer populations [8]. This evidence concerns the gene BRCA1 and pancreatic neoplasm.